Presented at: 2024 SITC Annual Meeting; November 6-10, 2024; Houston, TX. Abstract 521.2. Study of PYX-106 in solid tumors. ClinicalTrials.gov. Updated August 8, 2024. Accessed November 7, 2024. https://clinicaltrials.gov/s...
根据2024癌症免疫治疗学会(SITC)年会上公布的II期THIO-101试验(NCT05208944)的结果,首创的端粒靶向药物THIO与cemiplimab联合使用在检查点抑制剂耐药的晚期非小细胞肺癌(NSCLC)患者中显示出持久活性,较高的疾病控制率(DCR)和生存获益。采用18...
这一前沿性研究成果于近日先后被国际权威学术会议第4届国际疫苗大会(4th International Vaccines Congress (IVC) 2024)和癌症免疫疗法协会第39届年会(the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting)收录并邀请进行会议报告。 IVC和SITC都是免疫学领域的国际盛会。本届IVC大会以“增强免疫力:...
参考文献:Peters S,Lim SM,Ortega G,et al.Updated overall survival from PERLA a phase II randomized double-blind trial of dostarlimab+chemotherapy vs pembrolizumab+chemotherapy in metastatic non-squamous non-small cell lung cancer.Presented at the 2024 Society for Immunotherapy of Cancer Annual Meeti...
SITC 2024 Annual Review Meeting Briefing On February 15, 2025, SITC held 2024 annual review meeting. Chairman of the Board of Directors Yang Xianxiang, CEO Xue Mingyuan, heads of each company and above attended the meeting, and all the staff of SITC's subsidiaries participated in the meeting...
November 7 -2024, - At the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024), held in Houston, USA, from November 6 - 10, Akeso Biopharma (9926. HK) presented the mechanism of action (MOA) research findings of its innovative bispecific antibody, AK132, targeting...
Prev:CStone's CMO Dr. Qingmei Shi Attends World Companion Diagnostics & Liquid Biopsy Summit APAC, Shares Insights on Precision Medicine and Companion Diagnostics Co-developmentNext:CStone to Present Latest Clinical Data on CS5001 for Lymphoma at the 66th ASH Annual Meeting...
“SITC”) 2024 Annual Meeting. Theposter presentationincludes updated translational data highlighting the relationship between vaccine immunogenicity and DFS. The AMPLIFY-7P study is evaluating ELI-002 in patients with mKRAS-driven solid tumors following standard locoregional treatment and...
2022年癌症免疫治疗学会 (SITC)第37届年会和会前计划 (SITC 2022) 将于 2022 年 11 月 9 日至 13 日在波士顿的波士顿会展中心举行。37th Annual Meeting & Pre-Conference Programs (SITC 2022)作为专注于癌症免疫治疗的最大会议,年会和会前计划为来自学术界、监管机构和政府机构的国际领导者以及行业代表提供了...
SITC 2024 Annual Review Meeting Briefing On February 15, 2025, SITC held 2024 annual review meeting. Chairman of the Board of Directors Yang Xianxiang, CEO Xue Mingyuan, heads of each company and above attended the meeting, and all the staff of SITC's subsidiaries participated in the meeting...